These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23344621)

  • 21. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
    Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
    J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
    Lokras A; Foged C; Thakur A
    Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive imaging of lipid nanoparticle-mediated systemic delivery of small-interfering RNA to the liver.
    Tao W; Davide JP; Cai M; Zhang GJ; South VJ; Matter A; Ng B; Zhang Y; Sepp-Lorenzino L
    Mol Ther; 2010 Sep; 18(9):1657-66. PubMed ID: 20628357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial siRNA delivery in nonhuman primates using ionizable low-molecular weight polymeric nanoparticles.
    Khan OF; Kowalski PS; Doloff JC; Tsosie JK; Bakthavatchalu V; Winn CB; Haupt J; Jamiel M; Langer R; Anderson DG
    Sci Adv; 2018 Jun; 4(6):eaar8409. PubMed ID: 29963629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticle-delivered siRNA targeting Bruton's tyrosine kinase for rheumatoid arthritis therapy.
    Zhao G; Liu A; Zhang Y; Zuo ZQ; Cao ZT; Zhang HB; Xu CF; Wang J
    Biomater Sci; 2019 Nov; 7(11):4698-4707. PubMed ID: 31495833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vivo siRNA delivery to tumor cells and its application to cancer gene therapy].
    Takahashi Y; Nishikawa M; Takakura Y
    Yakugaku Zasshi; 2007 Oct; 127(10):1525-31. PubMed ID: 17917414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB-siRNA conjugates.
    Cuellar TL; Barnes D; Nelson C; Tanguay J; Yu SF; Wen X; Scales SJ; Gesch J; Davis D; van Brabant Smith A; Leake D; Vandlen R; Siebel CW
    Nucleic Acids Res; 2015 Jan; 43(2):1189-203. PubMed ID: 25550431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
    He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
    Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice.
    Kim SS; Peer D; Kumar P; Subramanya S; Wu H; Asthana D; Habiro K; Yang YG; Manjunath N; Shimaoka M; Shankar P
    Mol Ther; 2010 Feb; 18(2):370-6. PubMed ID: 19997090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding RNAi to Kidneys, Lungs, and Spleen via Selective ORgan Targeting (SORT) siRNA Lipid Nanoparticles.
    Vaidya A; Moore S; Chatterjee S; Guerrero E; Kim M; Farbiak L; Dilliard SA; Siegwart DJ
    Adv Mater; 2024 Jun; ():e2313791. PubMed ID: 38973655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
    Guo J; Russell EG; Darcy R; Cotter TG; McKenna SL; Cahill MR; O'Driscoll CM
    Mol Pharm; 2017 Mar; 14(3):940-952. PubMed ID: 28146632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA Interference Ex Vivo.
    Liu S
    Methods Mol Biol; 2018; 1868():129-135. PubMed ID: 30244460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse.
    Takanashi M; Oikawa K; Sudo K; Tanaka M; Fujita K; Ishikawa A; Nakae S; Kaspar RL; Matsuzaki M; Kudo M; Kuroda M
    Gene Ther; 2009 Aug; 16(8):982-9. PubMed ID: 19474812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.
    Khoury M; Escriou V; Courties G; Galy A; Yao R; Largeau C; Scherman D; Jorgensen C; Apparailly F
    Arthritis Rheum; 2008 Aug; 58(8):2356-67. PubMed ID: 18668557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of STAT3 via Peptidomimetic LNP-Mediated Systemic Delivery of RNAi Downregulates PD-L1 and Inhibits Melanoma Growth.
    Ehexige E; Bao M; Bazarjav P; Yu X; Xiao H; Han S; Baigude H
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32059541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.
    Aouadi M; Tesz GJ; Nicoloro SM; Wang M; Chouinard M; Soto E; Ostroff GR; Czech MP
    Nature; 2009 Apr; 458(7242):1180-4. PubMed ID: 19407801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emerging potential of siRNA nanotherapeutics in treatment of arthritis.
    Kumari A; Kaur A; Aggarwal G
    Asian J Pharm Sci; 2023 Sep; 18(5):100845. PubMed ID: 37881798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemia.
    Landry B; Gül-Uludağ H; Plianwong S; Kucharski C; Zak Z; Parmar MB; Kutsch O; Jiang H; Brandwein J; Uludağ H
    J Control Release; 2016 Feb; 224():8-21. PubMed ID: 26742943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.
    Xu Y; Ou M; Keough E; Roberts J; Koeplinger K; Lyman M; Fauty S; Carlini E; Stern M; Zhang R; Yeh S; Mahan E; Wang Y; Slaughter D; Gindy M; Raab C; Thompson C; Hochman J
    Mol Pharm; 2014 May; 11(5):1424-34. PubMed ID: 24588618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.